The Sol Goldman Pancreatic Cancer Research Center

Pancreas Multidisciplinary Cancer Team

Our Team

The Multidisciplinary Pancreatic Cancer Team at Johns Hopkins is committed to providing the highest level of care to individuals suffering from pancreatic cancer and related conditions. Our team is comprised of many of the world's leading experts in pancreatic cancer.


A Message of Hope...

A Message of Hope

On Saturday March 24, 2013, members of the Baltimore and the Washington, D.C. affiliates of PanCAN visited the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins. Approximately 50 patients, family members and advocates visited.
More...


Experience is Important

Surgeons at Johns Hopkins performed more pancreatic cancer resections than any other institution in the world. More...


Pancreatic Cancer News

2020 Cancer Statistics Released

The American Cancer Society just published, in the journal CA: A Cancer Journal for Clinicians, the latest cancer statistics in the United States. The authors report that "In 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States.
read more »



Two recently published papers highlight the risk of recurrence after the surgical resection of an intraductal papillary mucinous neoplasm of the pancreas

Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are non-invasive precancerous lesions, some of which, over time progress to invasive pancreatic cancer. If an intraductal papillary mucinous neoplasms of the pancreas is removed, it will not progress to invasive cancer. Intraductal papillary mucinous neoplasms of the pancreas therefore represent an opportunity to cure a pancreas tumor, before it becomes cancer... read more »


more news...


Support our Research!

Support

Donate to our Pancreatic Cancer Research, Raise Awareness, become Involved and Spread the Word. Private giving has provided us with the opportunity to make real advances in our understanding of pancreas cancer and it has provided critical support to our young investigators. Please consider supporting our research.

More...